4//SEC Filing
Adawi Kamal 4
Accession 0001193125-26-015323
CIK 0001434316other
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 4:02 PM ET
Size
7.2 KB
Accession
0001193125-26-015323
Insider Transaction Report
Form 4
Adawi Kamal
Chief Financial Officer
Transactions
- Award
Common Stock
[F1]2026-01-15+25,000→ 100,000 total - Award
Stock Option (Right to Buy)
[F2]2026-01-15+75,000→ 75,000 totalExercise: $1.05Exp: 2036-01-14→ Common Stock (75,000 underlying)
Footnotes (2)
- [F1]Award of restricted stock units ("RSUs") that vest with respect to 1/4th of the RSUs on each of January 8, 2027, January 8, 2028, January 8, 2029 and January 8, 2030, subject to the Reporting Person's continued service with the Issuer as of each such vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement.
- [F2]The shares subject to this option shall vest in 36 equal monthly installments following January 1, 2026, such that all of the shares shall be fully vested and exercisable on January 1, 2029, subject to the Reporting Person's continued service with the Issuer as of each such vesting date.
Signature
/s/ Cindy Tahl, as Attorney-in-Fact|2026-01-16
Documents
Issuer
FATE THERAPEUTICS INC
CIK 0001434316
Entity typeother
Related Parties
1- filerCIK 0001788393
Filing Metadata
- Form type
- 4
- Filed
- Jan 15, 7:00 PM ET
- Accepted
- Jan 16, 4:02 PM ET
- Size
- 7.2 KB